Bronchoalveolar Cell Lung Cancer Completed Phase 3 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0028477 (Bronchoalveolar Cell Lung Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00002852Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung CancerTreatment